Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 4:30 PM View:  | Aclaris Therapeutics, Inc. (ACRS) | 01-Jun-24 | Option Exercise | 4,660 | -- | -- | 38% 12.3K to 16.96K | |
| 11-Aug-23 4:48 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 10-Aug-23 | Sale | 51 | $0.51 | $26.01 | (100%) 51 to 0 | |
| 05-Jun-23 5:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-23 | Option Exercise | 4,507 | -- | -- | 58% 7.79K to 12.3K | |
| 06-Jun-22 5:15 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Jun-22 | Option Exercise | 3,356 | -- | -- | 76% 4.44K to 7.79K | |
| 09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-20 | Market Sale (Planned) | 4,567 | $12.05 | $55,032.40 | (16%) 28.7K to 24.13K | 75% |
| 09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 91% 15.0K to 28.7K | |
| 04-Mar-20 4:23 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-20 | Option Exercise | 4,438 | -- | -- | 100% 0 to 4.44K | |
| 10-Jun-19 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 1054% 1.3K to 15.0K | |
| 05-Feb-19 4:59 PM View: | Trevena, Inc. (TRVN) | 01-Feb-19 | Market Purchase | 50,000 | $1.02 | $51,000.00 | 12% 420.01K to 470.01K | (26%) |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 25-May-17 | Gift | 403 | -- | -- | < 1% 420.01K to 420.42K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 25-May-17 | Gift | 403 | -- | -- | (< 1%) 420.42K to 420.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 16-Mar-17 | Gift | 60,000 | -- | -- | 14% 420.01K to 480.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 16-Mar-17 | Gift | 60,000 | -- | -- | (12%) 480.01K to 420.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 13-Mar-17 | Gift | 50,000 | -- | -- | 12% 420.01K to 470.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 13-Mar-17 | Gift | 50,000 | -- | -- | (11%) 470.01K to 420.01K | |
| 27-Feb-17 8:34 AM View: | Trevena, Inc. (TRVN) | 23-Feb-17 | Option Exercise | 110,403 | $0.68 | $75,294.80 | 36% 309.61K to 420.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 23-Jan-17 | Gift | 12,500 | -- | -- | 3% 420.01K to 432.51K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 23-Jan-17 | Gift | 12,500 | -- | -- | (3%) 432.51K to 420.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 06-Jan-17 | Gift | 150,000 | -- | -- | 36% 420.01K to 570.01K | |
| 09-Jun-17 5:57 PM View: | Trevena, Inc. (TRVN) | 06-Jan-17 | Gift | 150,000 | -- | -- | (26%) 570.01K to 420.01K | |
| 05-Jan-17 4:29 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 04-Jan-17 | Grant | 7,000 | $1.50 | $10,500.00 | 66% 10.54K to 17.54K | (90%) |
| 09-Nov-16 5:37 PM View: | Trevena, Inc. (TRVN) | 07-Nov-16 | Market Purchase | 12,500 | $4.10 | $51,250.00 | 4% 297.11K to 309.61K | (83%) |
| 25-Oct-16 5:28 PM View: | Trevena, Inc. (TRVN) | 20-Oct-16 | Gift | 14,084 | -- | -- | 5% 297.11K to 311.19K | |
| 25-Oct-16 5:28 PM View: | Trevena, Inc. (TRVN) | 20-Oct-16 | Gift | 14,084 | -- | -- | (5%) 311.19K to 297.11K | |
| 19-Oct-16 4:43 PM View: | Trevena, Inc. (TRVN) | 17-Oct-16 | Gift | 145,025 | -- | -- | 49% 297.11K to 442.13K | |
| 19-Oct-16 4:43 PM View: | Trevena, Inc. (TRVN) | 17-Oct-16 | Gift | 145,025 | -- | -- | (33%) 442.13K to 297.11K | |
| 09-Jun-17 10:00 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 16-Oct-16 | Gift | 10,542 | -- | -- | (100%) (-10.54K) to 1 | |
| 05-Oct-16 4:52 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 03-Oct-16 | Market Purchase | 4,102 | $2.56 | $10,501.10 | 64% 6.44K to 10.54K | (94%) |
| 19-Oct-16 4:43 PM View: | Trevena, Inc. (TRVN) | 29-Sep-16 | Gift | 130,000 | -- | -- | 44% 297.11K to 427.11K | |
| 19-Oct-16 4:43 PM View: | Trevena, Inc. (TRVN) | 29-Sep-16 | Gift | 130,000 | -- | -- | (30%) 427.11K to 297.11K | |
| 06-Jul-16 5:16 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-16 | Grant | 6,441 | $1.63 | $10,498.80 | 100% 0 to 6.44K | (91%) |
| 31-May-16 5:34 PM View: | Trevena, Inc. (TRVN) | 27-May-16 | Market Purchase | 14,084 | $7.08 | $99,714.70 | 5% 283.02K to 297.11K | (90%) |
| 31-May-16 5:34 PM View: | Trevena, Inc. (TRVN) | 26-May-16 | Market Purchase | 4,000 | $7.19 | $28,760.00 | 1% 275.02K to 279.02K | (90%) |
| 31-May-16 5:34 PM View: | Trevena, Inc. (TRVN) | 26-May-16 | Market Purchase | 4,000 | $7.20 | $28,800.00 | 1% 279.02K to 283.02K | (90%) |
| 19-Mar-15 5:14 PM View: | Trevena, Inc. (TRVN) | 20-Feb-15 | Gift | 51,000 | -- | -- | (16%) 326.02K to 275.02K | |
| 10-Dec-14 5:54 PM View: | Trevena, Inc. (TRVN) | 10-Dec-14 | Market Purchase | 8,000 | $4.00 | $32,000.00 | 3% 318.02K to 326.02K | (83%) |
| 14-Nov-14 6:55 AM View: | Akebia Therapeutics, Inc. (AKBA) | 13-Nov-14 | Market Purchase | 1,300 | $11.82 | $15,364.70 | 100% 0 to 1.3K | (76%) |
| 15-May-14 9:37 PM View: | Trevena, Inc. (TRVN) | 23-Apr-14 | Option Exercise | 124,477 | $0.68 | $84,893.30 | 64% 193.55K to 318.02K | |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 17,343 | $14.25 | $247,138.00 | (61%) 28.66K to 11.32K | < 1% |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 11,320 | $14.25 | $161,312.00 | (100%) 11.32K to 0 | < 1% |
| 21-May-12 9:41 AM View: | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 10% 26.16K to 28.66K | |
| 16-May-11 11:32 AM View: | Human Genome Sciences Inc. (HGSI) | 12-May-11 | Grant | 2,500 | -- | -- | 11% 23.66K to 26.16K | |
| 23-Mar-11 3:08 PM View: | Human Genome Sciences Inc. (HGSI) | 21-Mar-11 | Market Sale | 7,926 | $27.29 | $216,293.00 | (25%) 31.59K to 23.66K | < 1% |
| 12-Jan-10 12:06 PM View: | Human Genome Sciences Inc. (HGSI) | 11-Jan-10 | Grant | 365 | $30.82 | $11,249.30 | 1% 31.22K to 31.59K | (21%) |
| 14-Oct-09 10:46 AM View: | Human Genome Sciences Inc. (HGSI) | 12-Oct-09 | Grant | 581 | $18.50 | $10,748.50 | 2% 30.64K to 31.22K | 31% |
| 14-Jul-09 10:06 AM View: | Human Genome Sciences Inc. (HGSI) | 10-Jul-09 | Grant | 4,249 | $2.53 | $10,750.00 | 16% 26.39K to 30.64K | 857% |
| 14-Apr-09 3:31 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Apr-09 | Grant | 13,218 | $0.87 | $11,499.70 | 100% 13.18K to 26.39K | 2697% |
| 13-Jan-09 2:59 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Jan-09 | Grant | 6,915 | $1.88 | $13,000.00 | 110% 6.26K to 13.18K | 1192% |
| 14-Oct-08 5:48 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Oct-08 | Grant | 4,043 | $3.71 | $15,000.00 | 182% 2.22K to 6.26K | 555% |
| 14-Jul-08 5:08 PM View: | Human Genome Sciences Inc. (HGSI) | 11-Jul-08 | Grant | 1,727 | $5.79 | $10,000.00 | 352% 0.49K to 2.22K | 319% |